Notably, increased incidence of grade≥3 hypertension was observed in heterozygous patients for VEGF-A promoter rs1005230 (p = 0.006), rs699947 (p = 0.006), and rs833061 (p = 0.010). Here, VEGFA is linked to Hypertension.